Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Treatment refractory schizophrenia.

Lindenmayer JP.

Psychiatr Q. 2000 Winter;71(4):373-84.

PMID:
11025914
2.

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G.

Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165.

3.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

4.

Practical issues with amisulpride in the management of patients with schizophrenia.

Pani L, Villagrán JM, Kontaxakis VP, Alptekin K.

Clin Drug Investig. 2008;28(8):465-77. Review.

PMID:
18598092
5.

Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.

Goodwin G, Fleischhacker W, Arango C, Baumann P, Davidson M, de Hert M, Falkai P, Kapur S, Leucht S, Licht R, Naber D, O'Keane V, Papakostas G, Vieta E, Zohar J.

Eur Neuropsychopharmacol. 2009 Jul;19(7):520-32. doi: 10.1016/j.euroneuro.2009.04.003. Epub 2009 May 2.

PMID:
19411165
6.

Augmentation strategies in clozapine-resistant schizophrenia.

Remington G, Saha A, Chong SA, Shammi C.

CNS Drugs. 2005;19(10):843-72. Review.

PMID:
16185094
7.

[Leponex, 10 years after -- a clinical review].

Llorca PM, Pere JJ.

Encephale. 2004 Sep-Oct;30(5):474-91. Review. French.

PMID:
15627052
8.

Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.

Houthoofd SA, Morrens M, Sabbe BG.

Clin Ther. 2008 Sep;30(9):1565-89. doi: 10.1016/j.clinthera.2008.09.014. Review.

PMID:
18840365
9.

Combination of "atypical" antipsychotic medication in the management of treatment-resistant schizophrenia and schizoaffective disorder.

Lerner V, Libov I, Kotler M, Strous RD.

Prog Neuropsychopharmacol Biol Psychiatry. 2004 Jan;28(1):89-98. Review.

PMID:
14687862
10.

Review: Combination therapy with non-clozapine atypical antipsychotic medication: a review of current evidence.

Chan J, Sweeting M.

J Psychopharmacol. 2007 Aug;21(6):657-64. Epub 2006 Nov 8. Review.

PMID:
17092976
11.

[Atypical antipsychotics and sexual dysfunction: five case-reports associated with risperidone].

Haefliger T, Bonsack C.

Encephale. 2006 Jan-Feb;32(1 Pt 1):97-105. French.

PMID:
16633296
12.

Children with schizophrenia: clinical picture and pharmacological treatment.

Masi G, Mucci M, Pari C.

CNS Drugs. 2006;20(10):841-66. Review.

PMID:
16999454
13.

The SOHO (Schizophrenia Outpatient Health Outcome) study: implications for the treatment of schizophrenia.

Haro JM, Salvador-Carulla L.

CNS Drugs. 2006;20(4):293-301. Review.

PMID:
16599647
14.

Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms.

Riedel M, Spellmann I, Strassnig M, Douhet A, Dehning S, Opgen-Rhein M, Valdevit R, Engel RR, Kleindienst N, Müller N, Möller HJ.

Eur Arch Psychiatry Clin Neurosci. 2007 Sep;257(6):360-70. Epub 2007 Jul 14.

PMID:
17629731
15.
16.

Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review.

Gao K, Muzina D, Gajwani P, Calabrese JR.

J Clin Psychiatry. 2006 Sep;67(9):1327-40. Review.

PMID:
17017818
17.

Impact of atypical antipsychotics on quality of life in patients with schizophrenia.

Awad AG, Voruganti LN.

CNS Drugs. 2004;18(13):877-93. Review.

PMID:
15521791
18.

[Pharmacologic and cognitive therapy treatment strategies in in persistent negative schizophrenic symptoms].

Vauth R, Dreher-Rudolph M, Stieglitz RD.

Fortschr Neurol Psychiatr. 1999 Jun;67(6):261-73. Review. German.

PMID:
10399046
19.

Current therapy issues and unmet clinical needs in the treatment of schizophrenia: a review of the new generation antipsychotics.

Lublin H, Eberhard J, Levander S.

Int Clin Psychopharmacol. 2005 Jul;20(4):183-98. Review.

PMID:
15933479
20.

Supplemental Content

Support Center